Oncolytics Biotech Inc ONC-CA:Toronto Stock Exchange

*Data is delayed | Exchange | CAD
Last | 04/18/24 EDT
1.43UNCH (UNCH)
52 week range
1.20 - 4.49
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.43
  • 52 Week High4.49
  • 52 Week High Date06/23/23
  • 52 Week Low1.20
  • 52 Week Low Date02/07/24

Key Stats

  • Market Cap84.35M
  • Shares Out75.42M
  • 10 Day Average Volume86,892.2
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change-20.11

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.43
  • 52 Week High4.49
  • 52 Week High Date06/23/23
  • 52 Week Low1.20
  • 52 Week Low Date02/07/24
  • Market Cap84.35M
  • Shares Out75.42M
  • 10 Day Average Volume86,892.2
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change-20.11

RATIOS/PROFITABILITY

  • EPS (TTM)-0.41
  • P/E (TTM)-3.45
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Oncolytics Biotech Inc

 

Profile

MORE
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune...
Wayne Pisano
Independent Chairman of the Board
Matthew Coffey Ph.D.
President, Chief Executive Officer, Director
Kirk Look
Chief Financial Officer
Allison Hagerman
Vice President - Product Development
Address
1167 Kensington Cres Nw Suite 210
Calgary Alberta Canada T2n 1X7
Calgary, AB
T2R 0C5
Canada

Top Peers

SYMBOLLASTCHG%CHG
DMAC
DiaMedica Therapeutics Inc
2.49-0.11-4.23%
EPRX
Eupraxia Pharmaceuticals Inc
2.51-0.16-5.82%
MDNA
Medicenna Therapeutics Corp
1.67UNCHUNCH
SVA
Sinovac Biotech Ltd
6.47-0.02-0.31%
ARCH
Arch Resources Inc
162.82-1.48-0.90%